Effects of tamoxifen and retinoic acid on cell growth and c-mgc gene expression in human breast and cervical cancer cells

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4557-4562

  Tsai, Lai Chen ^a   Hung, Mei Whey ^a   Yuan, Chiou Chung ^a   Chao, Pei Ling ^a   Jiang, Shu Yuan ^b   Chang, Gu Gang ^b   Chang, Tsu Chung ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

c myc; Estrogen; Retinoic acid; Tamoxifen

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; RETINOIC ACID; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; KINETICS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TAMOXIFEN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031409602     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kon OL: Estrogens, antiestrogens and cell proliferation. Bioessays 10: 210-214, 1989
2. Webb P, Lopez GN, Uh RM and Kushner PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9: 443-455, 1995
3. Hwang JY, Lin BY, Tang FM and Yu WCY: Tamoxifen stimulates human papillomavirus type 16 gene expression and cell proliferation in a cervical cancer cell line. Cancer Res 5: 6848-6852, 1992
4. Tang BL, TeG CC, Sim KY, Ng ML and Kon OL: Cytostatic effect of antiestrogens in lymphoid cells: relationship to high affinity antiestrogen-binding sites and cholesterol. Biochim Biophys Acta 1014: 162-172, 1989
5. Cavailles V, Garcia M and Rochefort H: Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mo, Endocrinol 3: 552-558, 1989
6. Lachman HM and Skoultchi Al: Expression of c-myc changes during differentiation of mouse eythroleukemia cells. Nature 310: 592-594, 1983.
7. Myers SL, O'Brien MT, Smith T and Dudley JP: Aanlysis of the iraint-2, c-myc and neu oncogenes in human breast cancer carcinomas. Cancer Res 50: 5911-5918, 1990 .
8. Machotka SV, Garrett CT, Sctwartz AM and Callahan R: Amplification of the proto-oncogenes int-2, c-erbB-2 and c-myc in human breast cancer. Clin Chim Acta 184: 207-218, 1989 .
9. Berns EMJJ, Klijn JGM, van Putten WU, van Staveren IL, Portengen H and Foekens JA: c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 52: 1107-1113, 1992.
10. Dubik D and Shiu RPC: Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7: 1587-1594, 1992.
11. Demirpence E, Balaguer P, Trousse F, Nicolas J-C, Pons M and Gagne D: Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54: 1458-1464, 1994.
12. Bulter WB and Fontana JA. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell lines MCF-7. Cancer Res 52: 6164-6167, 1992.
13. Chang T-C, Wang J-K, Hung M-W, Chiao C-H, Tsai L-C and Chang G-G: Regulation of the expression of alkaline phosphatase in a human breast cancer line, BC-M1. Biochem J 303: 199-205, 1994.
14. Ko JK, Chang CM, Chao KC, Wu KD, Ng HT and Hu CP: Establishment and characterization of human cervical carcinoma cells in continuous culture. Chin J Microbiol Immunol 13: 273, 1980 .
15. Grenaman S, Shapira A and Carey TE: In vitro response of cervical cancer cell lines CaSki, HeLa, and ME180 to the antiestrogen tamoxifen. Gynecol Oncol 30: 228-238, 1988.
16. Choo KB, Chong KY, Chou HF, Liew LN and Liou CC: Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines. Biochem Biophys Res Commun 158: 334-340, 1989.
17. Fontana JA, Nervi C, Shao Z-M and Jetten AM: Retinoid antagonism of estrogen-responsive transforming growth factor α and pS2 gene expression in breast carcinoma cells. Cancer Res 52: 3938-3945, 1992 .
18. Dubik D and Shiu RPC: Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem 263: 12705-12708, 1988.
19. Miller MA and Katzenellenbogen BS: Characterization and quantitation of antiestrogen binding sites in estrogen-receptor-positive and negative human breast cancer cell lines. Cancer Res 43: 3094-3100, 1983.
20. Santos GF, Scott GK, Lee WM, Liu E and Benz C: Estrogen-induced posttranscriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem 263: 9565-9568, 1988.
21. Fontana JA: Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp Cell Biol 55: 136-144, 1987
22. Demirpence E, Pons M, Balaguer P and Gagne D: Study of an antiestrogenic effect of retinoic acid in MCF-7 cells. Biochem Biophys Res Commun 183: 100-106, 1992